Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTInhibitors of CD73 May Provide a Treatment for Cancer and Autoimmune DiseasesAhmed F. Abdel-Magid*View Author Information Therachem Research Medilab (India) Pvt. Ltd., Jaipur, India*Address: 1383 Jasper Drive, Ambler, Pennsylvania 19002, United States. Tel: 215-913-7202. E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2017, 8, 8, 781–782Publication Date (Web):July 6, 2017Publication History Received26 June 2017Published online6 July 2017Published inissue 10 August 2017https://doi.org/10.1021/acsmedchemlett.7b00255Copyright © 2017 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views2655Altmetric-Citations5LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (218 KB) Get e-AlertsSUBJECTS:Cancer,Cells,Inhibitors,Nucleic acids,Tumors Get e-Alerts
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
